Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BACK vs USPH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BACK
IMAC Holdings, Inc.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$77K
5Y Perf.-99.9%
USPH
U.S. Physical Therapy, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$1.12B
5Y Perf.-0.7%

BACK vs USPH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BACK logoBACK
USPH logoUSPH
IndustryMedical - Care FacilitiesMedical - Care Facilities
Market Cap$77K$1.12B
Revenue (TTM)$23K$695M
Net Income (TTM)$-10M$11M
Gross Margin-18.4%22.0%
Operating Margin-398.1%12.2%
Forward P/E25.7x
Total Debt$0.00$426M
Cash & Equiv.$504K$36M

BACK vs USPHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BACK
USPH
StockMay 20May 26Return
IMAC Holdings, Inc. (BACK)1000.1-99.9%
U.S. Physical Thera… (USPH)10099.3-0.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: BACK vs USPH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: USPH leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. IMAC Holdings, Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
BACK
IMAC Holdings, Inc.
The Income Pick

BACK is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 1 yrs, beta 0.05, yield 100.0%
  • Lower volatility, beta 0.05, current ratio 0.09x
  • Beta 0.05, yield 100.0%, current ratio 0.09x
Best for: income & stability and sleep-well-at-night
USPH
U.S. Physical Therapy, Inc.
The Growth Play

USPH carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 16.3%, EPS growth -22.8%, 3Y rev CAGR 12.2%
  • 52.5% 10Y total return vs BACK's -100.0%
  • 16.3% revenue growth vs BACK's -98.6%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthUSPH logoUSPH16.3% revenue growth vs BACK's -98.6%
Quality / MarginsUSPH logoUSPH1.5% margin vs BACK's -426.9%
Stability / SafetyBACK logoBACKBeta 0.05 vs USPH's 0.93
DividendsBACK logoBACK100.0% yield, 1-year raise streak, vs USPH's 2.4%
Momentum (1Y)USPH logoUSPH+5.4% vs BACK's -15.6%
Efficiency (ROA)USPH logoUSPH0.9% ROA vs BACK's -31.3%

BACK vs USPH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BACKIMAC Holdings, Inc.

Segment breakdown not available.

USPHU.S. Physical Therapy, Inc.
FY 2025
Net Patient Revenues
83.3%$650M
Other Revenues Including Management Contract Revenues and Industrial Injury Prevention Services Revenues
16.7%$131M

BACK vs USPH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUSPHLAGGINGBACK

Income & Cash Flow (Last 12 Months)

USPH leads this category, winning 5 of 6 comparable metrics.

USPH is the larger business by revenue, generating $695M annually — 30597.2x BACK's $22,723. USPH is the more profitable business, keeping 1.5% of every revenue dollar as net income compared to BACK's -426.9%. On growth, USPH holds the edge at +7.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBACK logoBACKIMAC Holdings, In…USPH logoUSPHU.S. Physical The…
RevenueTrailing 12 months$22,723$695M
EBITDAEarnings before interest/tax-$9M$107M
Net IncomeAfter-tax profit-$10M$11M
Free Cash FlowCash after capex-$5M$67M
Gross MarginGross profit ÷ Revenue-18.4%+22.0%
Operating MarginEBIT ÷ Revenue-398.1%+12.2%
Net MarginNet income ÷ Revenue-426.9%+1.5%
FCF MarginFCF ÷ Revenue-215.1%+9.6%
Rev. Growth (YoY)Latest quarter vs prior year-62.3%+7.7%
EPS Growth (YoY)Latest quarter vs prior year+26.3%-115.0%
USPH leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

BACK leads this category, winning 2 of 2 comparable metrics.
MetricBACK logoBACKIMAC Holdings, In…USPH logoUSPHU.S. Physical The…
Market CapShares × price$77,135$1.1B
Enterprise ValueMkt cap + debt − cash-$427,054$1.5B
Trailing P/EPrice ÷ TTM EPS-0.00x51.84x
Forward P/EPrice ÷ next-FY EPS est.25.74x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple14.68x
Price / SalesMarket cap ÷ Revenue1.07x1.43x
Price / BookPrice ÷ Book value/share1.45x
Price / FCFMarket cap ÷ FCF18.35x
BACK leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

USPH leads this category, winning 3 of 5 comparable metrics.

On the Piotroski fundamental quality scale (0–9), USPH scores 5/9 vs BACK's 1/9, reflecting solid financial health.

MetricBACK logoBACKIMAC Holdings, In…USPH logoUSPHU.S. Physical The…
ROE (TTM)Return on equity+1.4%
ROA (TTM)Return on assets-31.3%+0.9%
ROICReturn on invested capital+5.6%
ROCEReturn on capital employed+7.6%
Piotroski ScoreFundamental quality 0–915
Debt / EquityFinancial leverage0.55x
Net DebtTotal debt minus cash-$504,189$390M
Cash & Equiv.Liquid assets$504,189$36M
Total DebtShort + long-term debt$0$426M
Interest CoverageEBIT ÷ Interest expense-28.20x15.42x
USPH leads this category, winning 3 of 5 comparable metrics.

Total Returns (Dividends Reinvested)

USPH leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in USPH five years ago would be worth $7,031 today (with dividends reinvested), compared to $7 for BACK. Over the past 12 months, USPH leads with a +5.4% total return vs BACK's -15.6%. The 3-year compound annual growth rate (CAGR) favors USPH at -11.6% vs BACK's -80.3% — a key indicator of consistent wealth creation.

MetricBACK logoBACKIMAC Holdings, In…USPH logoUSPHU.S. Physical The…
YTD ReturnYear-to-date-69.8%-6.1%
1-Year ReturnPast 12 months-15.6%+5.4%
3-Year ReturnCumulative with dividends-99.2%-30.9%
5-Year ReturnCumulative with dividends-99.9%-29.7%
10-Year ReturnCumulative with dividends-100.0%+52.5%
CAGR (3Y)Annualised 3-year return-80.3%-11.6%
USPH leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BACK and USPH each lead in 1 of 2 comparable metrics.

BACK is the less volatile stock with a 0.05 beta — it tends to amplify market swings less than USPH's 0.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. USPH currently trades 78.7% from its 52-week high vs BACK's 18.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBACK logoBACKIMAC Holdings, In…USPH logoUSPHU.S. Physical The…
Beta (5Y)Sensitivity to S&P 5000.05x0.93x
52-Week HighHighest price in past year$0.21$93.50
52-Week LowLowest price in past year$0.03$66.67
% of 52W HighCurrent price vs 52-week peak+18.1%+78.7%
RSI (14)Momentum oscillator 0–10040.836.2
Avg Volume (50D)Average daily shares traded3K164K
Evenly matched — BACK and USPH each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — BACK and USPH each lead in 1 of 2 comparable metrics.

For income investors, BACK offers the higher dividend yield at 100.00% vs USPH's 2.45%.

MetricBACK logoBACKIMAC Holdings, In…USPH logoUSPHU.S. Physical The…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$102.00
# AnalystsCovering analysts12
Dividend YieldAnnual dividend ÷ price+100.0%+2.4%
Dividend StreakConsecutive years of raises15
Dividend / ShareAnnual DPS$0.80$1.80
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.5%
Evenly matched — BACK and USPH each lead in 1 of 2 comparable metrics.
Key Takeaway

USPH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BACK leads in 1 (Valuation Metrics). 2 tied.

Best OverallU.S. Physical Therapy, Inc. (USPH)Leads 3 of 6 categories
Loading custom metrics...

BACK vs USPH: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is BACK or USPH a better buy right now?

For growth investors, U.

S. Physical Therapy, Inc. (USPH) is the stronger pick with 16. 3% revenue growth year-over-year, versus -98. 6% for IMAC Holdings, Inc. (BACK). U. S. Physical Therapy, Inc. (USPH) offers the better valuation at 51. 8x trailing P/E (25. 7x forward), making it the more compelling value choice. Analysts rate U. S. Physical Therapy, Inc. (USPH) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — BACK or USPH?

Over the past 5 years, U.

S. Physical Therapy, Inc. (USPH) delivered a total return of -29. 7%, compared to -99. 9% for IMAC Holdings, Inc. (BACK). Over 10 years, the gap is even starker: USPH returned +52. 5% versus BACK's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — BACK or USPH?

By beta (market sensitivity over 5 years), IMAC Holdings, Inc.

(BACK) is the lower-risk stock at 0. 05β versus U. S. Physical Therapy, Inc. 's 0. 93β — meaning USPH is approximately 1931% more volatile than BACK relative to the S&P 500.

04

Which is growing faster — BACK or USPH?

By revenue growth (latest reported year), U.

S. Physical Therapy, Inc. (USPH) is pulling ahead at 16. 3% versus -98. 6% for IMAC Holdings, Inc. (BACK). On earnings-per-share growth, the picture is similar: IMAC Holdings, Inc. grew EPS -5. 4% year-over-year, compared to -22. 8% for U. S. Physical Therapy, Inc.. Over a 3-year CAGR, USPH leads at 12. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — BACK or USPH?

U.

S. Physical Therapy, Inc. (USPH) is the more profitable company, earning 1. 9% net margin versus -125. 5% for IMAC Holdings, Inc. — meaning it keeps 1. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: USPH leads at 10. 3% versus -78. 0% for BACK. At the gross margin level — before operating expenses — USPH leads at 20. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — BACK or USPH?

All stocks in this comparison pay dividends.

IMAC Holdings, Inc. (BACK) offers the highest yield at 100. 0%, versus 2. 4% for U. S. Physical Therapy, Inc. (USPH).

07

Is BACK or USPH better for a retirement portfolio?

For long-horizon retirement investors, IMAC Holdings, Inc.

(BACK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 05), 100. 0% yield). Both have compounded well over 10 years (BACK: -100. 0%, USPH: +52. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between BACK and USPH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: BACK is a small-cap income-oriented stock; USPH is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BACK

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $2B
  • Dividend Yield > 40.0%
Run This Screen
Stocks Like

USPH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BACK and USPH on the metrics below

Revenue Growth>
%
(BACK: -62.3% · USPH: 7.7%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.